Calypte Biomedical Corp

Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.1
from S-8 ~20 pages Indenture or similar
12/34/56
EX-4.1
from S-8 ~10 pages Indenture or similar
12/34/56
EX-4.1
from S-8 ~10 pages Indenture or similar
12/34/56
EX-4.3
from S-8 ~10 pages Indenture or similar
12/34/56
EX-4.2
from S-8 ~10 pages Indenture or similar
12/34/56
EX-4.1
from S-8 ~10 pages Indenture or similar
12/34/56
EX-4.1
from S-8 ~20 pages Indenture or similar
12/34/56
EX-4.2
from S-8 ~10 pages Indenture or similar
12/34/56
EX-4.1
from S-8 ~20 pages Indenture or similar
12/34/56
EX-4.2
from S-8 8 pages Calypte Biomedical Corporation Common Stock Purchase Warrant to Purchase Shares of Common Stock This Common Stock Purchase Warrant Is Issued To: [Name] [Address] [City, State Zip]
12/34/56
EX-4.1(J)
from S-8 1 page Amendment 1 to Consulting Agreement Between Calypte Biomedical Corporation and Todd Govig
12/34/56
EX-4.1(H)
from S-8 4 pages Consulting Agreement
12/34/56
EX-4.1(G)
from S-8 1 page Amendment 1 to Consulting Agreement Between Calypte Biomedical Corporation and Jeff W. Morgan
12/34/56
EX-4.1(F)
from S-8 1 page Amendment 1 to Consulting Agreement Between Calypte Biomedical Corporation and Jonathan Bernstein
12/34/56
EX-4.1(E)
from S-8 1 page Amendment No. 3 to Consulting Agreement Between Calypte Biomedical Corporation and Sadegh Panahi
12/34/56
EX-4.1(D)
from S-8 5 pages Calypte. These Initial Introductions Would Be in State and National Government, the Military, the Corrections Industry, as Well as Agencies and Elected Officials to Be Defined in Our Overall Plan. • Provide Access and Present Opportunities With Other Health Care Providers, Including Hospital and Insurance Companies – As Well as State and National Budget Decision-Makers Concerned With Stretching Tax Revenue. • Provide “Message” Recommendations for Approaching Different Industries and Governments, and Specific Individuals in Each. • Prepare Written Materials for Presentation to Decision Makers. • Facilitate Follow-Up and Information Sharing After Initial Meetings to Move Initial Contacts to Real Support and Action for Calypte. Increasing Awareness and Acceptance • Identify and Secure Opportunities for Calypte Representatives to Present the Company’s Products – Including Medical, Dental, Health Care, Public Health, Service and Taxpayer Groups
12/34/56
EX-4.1(C)
from S-8 1 page Amendment No. 1 to Consulting Agreement Between Calypte Biomedical Corporation and Peter C. Pang
12/34/56
EX-4.1(B)
from S-8 5 pages Advisory Agreement Between Calypte Biomedical Corporation and Jeff Georgino
12/34/56
EX-4.1(A)
from S-8 4 pages Consulting Agreement 10
12/34/56
EX-4.1
from S-8 1 page Number of Shares and Warrants 4.1(a) 9,600,000 4.1(b) 10,400,000 4.1(c) 3,000,000 4.1(d) 5,000,000 4.1(e) 5,000,000 4.1(f) 1,700,000 4.1(g) 240,000 4.1(h) 8,000,000 4.1(j) 900,000 Other 200,000 Total 44,040,000 9
12/34/56